Skip to main content
WHAT A WASTE

Americans Shun Johnson & Johnson COVID Vaccine

Millions of doses will probably expire before they can be used in the U.S.

GettyImages-1231560342_f1feis

Michael Ciaglo/Getty

By Tracy Connor

The Johnson & Johnson vaccine was supposed to be a COVID game-changer. Instead it turned out the “one-and-done” jab didn't have any game. The New York Times reports that only 4 percent of all coronavirus doses given have been the J&J variety—which was plagued by delays and then linked to a small number of blood-clot incidents. Millions of doses will likely expire before states can find anyone to take them—and J&J is now concentrating on the global market. “It’s just not what I think anybody would have hoped it would be when it came out,” Dave Baden of the Oregon Health Authority told the Times.

Read it at The New York Times

TRENDING NOW